The immunology of tuberculosis: From bench to bedside
Tóm tắt
Tuberculosis (TB) is an international public health priority and kills almost two million people annually. TB is out of control in Africa due to increasing poverty and HIV coinfection, and drug‐resistant TB threatens to destabilize TB control efforts in several regions of the world. Existing diagnostic tools and therapeutic interventions for TB are suboptimal. Thus, new vaccines, immunotherapeutic interventions and diagnostic tools are urgently required to facilitate TB control efforts. An improved understanding of the immunopathogenesis of TB can facilitate the identification of correlates of immune protection, the design of effective vaccines, the rational selection of immunotherapeutic agents, the evaluation of new drug candidates, and drive the development of new immunodiagnostic tools. Here we review the immunology of TB with a focus on aspects that are clinically and therapeutically relevant. An immunologically orientated approach to tackling TB can only succeed with concurrent efforts to alleviate poverty and reduce the global burden of HIV.
Từ khóa
Tài liệu tham khảo
World Health Organization, 2009, Global Tuberculosis Control 2009: Epidemiology, Strategy, Financing
World Health Organization, 2008, Anti‐Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti‐Tuberculosis Drug Resistance Surveillance
Hanekom WA, 2007, Immunological protection against tuberculosis, S. Afr. Med. J., 97, 973
Dahl KE, 1996, Selective induction of transforming growth factor beta in human monocytes bylipoarabinomannan of Mycobacterium tuberculosis, Infect. Immun., 64, 399, 10.1128/iai.64.2.399-405.1996
Bocchino M, 2000, Mycobacterium tuberculosis and HIV co‐infection in the lung: synergic immune dysregulation leading to disease progression, Monaldi Arch. Chest Dis., 55, 381
World Health Organization.Report of the expert consultation on immunotherapeutic interventions for tuberculosis. Geneva 29–31 January2007. [Accessed October 2009.] Available from URL:http://apps.who.int/tdr/svc/publications/tdr‐research‐publications/immunotherapeutic‐interventions‐tb
Fan MCX, 2007, Adjuvant effect of Mycobacterium vaccae on treatment of recurrent treated pulmonary tuberculosis: a meta‐analysis, Chin. J. Evid. Based Med., 7, 449
Von Reyn CF, 2008, [PS‐ 81689‐20] The DarDar prime‐boost TB vaccine trial in HIV infection: final results, Int. J. Tuberc. Lung Dis., 12, S318
Prihoda ND, 2008, Adjunct immunotherapy of tuberculosis in drug‐resistant TB and TB/HIV co‐infected patients, Int. J. Biomed. Pharm. Sci., 2, 59
Patel N, 2002, Effect of an immunomodulator containing Mycobacterium w on sputum conversion in pulmonary tuberculosis, J. Indian Med. Assoc., 100, 191
Immanuel C, 2001, Serial evaluation of serum neopterin in HIV seronegative patients treated for tuberculosis, Int. J. Tuberc. Lung Dis., 5, 185
Bajaj G, 1989, Prognostic value of ‘C’ reactive protein in tuberculosis, Indian Pediatr., 26, 1010
Torres M, 1998, Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30‐kilodalton antigen of Mycobacterium tuberculosis, Infect. Immun., 66, 176, 10.1128/IAI.66.1.176-180.1998
Lotte A, 1984, A bibliography of the complications of BCG vaccination. A comprehensive list of the world literature since the introduction of BCG up to July 1982, supplemented by over 100 personal communications, Adv. Tuberc. Res., 21, 194
Hesseling AC, 2008, Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV‐infected infants, Int. J. Tuberc. Lung Dis., 12, 1376
Resende CT, 2007, Intestinal helminth co‐infection has a negative impact on both anti‐Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy, Clin. Exp. Immunol., 147, 219
Malhotra I, 1999, Helminth‐ and Bacillus Calmette‐Guerin‐induced immunity in children sensitized in utero to filariasis and schistosomiasis, J. Immunol., 162, 6843, 10.4049/jimmunol.162.11.6843
World Health Organization, 2007, Revised BCG vaccination guidelines for infants at risk for HIV infection, Wkly. Epidemiol. Rec., 82, 193
CashmoreT Van Zyl‐SmitRN DhedaKet al.Feasibility and diagnostic utility of antigen‐specific ifn‐γ responses for the rapid immunodiagnosis of tb using induced sputum.(Abstract) 2nd International IGRA Symposium Dubrovnik;2009.
Thomas MM, 2008, Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen‐specific T‐cells, Int. J. Tuberc. Lung Dis., 12, 651
Van Zyl‐SmitRN PatelV DhedaKet al.Rapid site‐specific immunodiagnosis of tuberculosis: is it useful in clinical practice in South Africa?(Abstract) 2nd International IGRA Symposium Dubrovnik;2009.
Comstock GW, 1978, Tuberculosis in twins: a re‐analysis of the Prophit survey, Am. Rev. Respir. Dis., 117, 621
Grzybowski S, 1975, Contacts of cases of active pulmonary tuberculosis, Bull. Int. Union Tuberc., 50, 90
Mazurek GH, 2005, Guidelines for using the QuantiFERON‐TB Gold test for detecting Mycobacterium tuberculosis infection, United States, MMWR Recomm. Rep., 54, 49
Patel V, 2010, Cerebrospinal T cell responses aid the diagnosis of tuberculous meningitis in a HIV and TB endemic population, AJRCCM